Skip to content

APOTEEK ROOYACKERS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTEEK ROOYACKERS

BE 0429.921.816
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€133,723
2024 · €117,802+€15,921
Equity
€780,104
2024 · €776,381+€3,723
Cash
€300,795
2024 · €483,803-€183,009
Balance sheet total
€1.1m
2024 · €1.3m-€154,094

Largest movements

2024 to 2025
Assets
  • Cash -€183,009

    down €183,009 (-37.8%), from €483,803 to €300,795

    mainly Contributions, distributions and other (-€130,000) and Trade debts (-€84,031)

  • Receivables within one year +€64,553

    up €64,553 (+29.4%), from €219,198 to €283,751

    of which Trade receivables: +€41,557

  • Tangible fixed assets -€35,259

    down €35,259 (-11.3%), from €312,933 to €277,674

    of which Plant, machinery and equipment: -€25,464

Equity and liabilities
  • Trade debts -€84,031

    down €84,031 (-23.4%), from €358,527 to €274,496

  • Tax, wage and social debts -€36,253

    down €36,253 (-36.7%), from €98,688 to €62,435

    of which Taxes: -€21,567

  • Current portion of long-term debt -€32,307

    down €32,307 (-100%), from €32,307 to €0

Income statement
  • Gross operating margin +€37,785

    up €37,785 (+5.6%), from €680,426 to €718,211

  • Staff costs +€24,883

    up €24,883 (+6.8%), from €366,041 to €390,923

  • Depreciation -€7,478

    down €7,478 (-13.9%), from €53,916 to €46,438

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €117,802
Gross operating margin +€37,785
Staff costs -€24,883
Depreciation +€7,478
Other operating charges +€304
Financial income +€240
Financial charges +€361
Taxes -€5,363
Result 2025 €133,723
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€9,523
Investment -€11,179
Financing -€162,307
Cash 2024 €483,803
Net result for the year +€133,723
Depreciation +€46,438
Stocks and contracts +€10,438
Receivables within one year -€64,553
Deferred charges and accrued income -€10,058
Trade debts -€84,031
Tax, wage and social debts -€36,253
Accrued charges and deferred income -€5,228
Investment in fixed assets (net) -€11,179
Current portion of long-term debt -€32,307
Contributions, distributions and other -€130,000
Cash 2025 €300,795
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,278,507 €1,124,412 -€154,094 -12.1%
Fixed assets 21/28 €312,933 €277,674 -€35,259 -11.3%
Tangible fixed assets 22/27 €312,933 €277,674 -€35,259 -11.3%
Land and buildings 22 €78,359 €68,564 -€9,795 -12.5%
Plant, machinery and equipment 23 €234,574 €209,110 -€25,464 -10.9%
Current assets 29/58 €965,574 €846,738 -€118,836 -12.3%
Stocks and contracts in progress 3 €246,930 €236,492 -€10,438 -4.2%
Stocks 30/36 €246,930 €236,492 -€10,438 -4.2%
Amounts receivable within one year 40/41 €219,198 €283,751 +€64,553 +29.4%
Trade receivables 40 €183,533 €225,090 +€41,557 +22.6%
Other amounts receivable 41 €35,665 €58,661 +€22,996 +64.5%
Cash at bank and in hand 54/58 €483,803 €300,795 -€183,009 -37.8%
Deferred charges and accrued income 490/1 €15,643 €25,701 +€10,058 +64.3%
Total equity and liabilities 10/49 €1,278,507 €1,124,412 -€154,094 -12.1%
Equity 10/15 €776,381 €780,104 +€3,723 +0.5%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €757,789 €761,512 +€3,723 +0.5%
Tax-exempt reserves 132 €357 €357 = 0.0%
Distributable reserves 133 €757,432 €761,155 +€3,723 +0.5%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €502,126 €344,308 -€157,818 -31.4%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €489,521 €336,932 -€152,590 -31.2%
Current portion of amounts payable after more than one year 42 €32,307 €0 -€32,307 -100%
Trade debts 44 €358,527 €274,496 -€84,031 -23.4%
Suppliers 440/4 €358,527 €274,496 -€84,031 -23.4%
Taxes, remuneration and social security 45 €98,688 €62,435 -€36,253 -36.7%
Taxes 450/3 €33,502 €11,934 -€21,567 -64.4%
Remuneration and social security 454/9 €65,187 €50,501 -€14,685 -22.5%
Other amounts payable 47/48 €0 - =
Accrued charges and deferred income 492/3 €12,605 €7,377 -€5,228 -41.5%
Remuneration, social security and pensions 62 €366,041 €390,923 +€24,883 +6.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €53,916 €46,438 -€7,478 -13.9%
Other operating charges 640/8 €3,682 €3,379 -€304 -8.2%
Gross operating margin 9900 €680,426 €718,211 +€37,785 +5.6%
Operating profit (loss) 9901 €256,787 €277,471 +€20,684 +8.1%
Financial income 75/76B €2,188 €2,428 +€240 +11.0%
Recurring financial income 75 €2,188 €2,428 +€240 +11.0%
Financial charges 65/66B €99,131 €98,771 -€361 -0.4%
Recurring financial charges 65 €99,131 €98,771 -€361 -0.4%
Profit (loss) for the period before taxes 9903 €159,844 €181,128 +€21,284 +13.3%
Income taxes 67/77 €42,042 €47,405 +€5,363 +12.8%
Profit (loss) for the period 9904 €117,802 €133,723 +€15,921 +13.5%
Profit (loss) for the period to be appropriated 9905 €117,802 €133,723 +€15,921 +13.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.